ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1507

Propylthiouracil Reduces Fibrosis in Chronic Oxidant Stress Mouse Model of Scleroderma

Gianluca Bagnato1, Alessandra Bitto2, Natasha Irrera2, Gabriele Pizzino2, Neal Roberts3, Maurizio Cinquegrani4, Donatella Sangari1, Francesco Squadrito2, Gianfilippo Bagnato1 and Antonino Saitta4, 1Rheumatology, University of Messina, Messina, Italy, 2Pharmacology, University of Messina, Messina, Italy, 3Medical College of Virginia, Richmond, VA, 4Internal Medicine, University of Messina, Messina, Italy

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, Cutaneous manifestations, pulmonary complications, scleroderma and thyroid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud’s – Pathogenesis, Animal Models and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic sclerosis (SSc) is characterized by fibrosis of skin and visceral organs; vascular damage and resultant ischemia; and immunological dysregulation manifested by autoantibodies. Hypothyroidism, induced by either propylthiouracil (PTU) or thyroidectomy, has been shown to induce regression of  pulmonary hypertension in the sumatinib/hypoxia rat model involving blockade of vascular endothelial growth factor (VEGF). The aim of this study was therefore to evaluate the effect of PTU in another murine model closer to human SSc, a mouse model of diffuse SSc reported to cause the development of anti-topoisomerase antibodies.

 

Methods: SSc was induced in BALB/c mice by daily subcutaneous injections of HOCl as an oxidant stress for 6 weeks (Batteux F, Kavian N, Servettaz A. New insights on chemically induced animal models of systemic sclerosis.Curr Opin Rheumatol. 2011 Nov;23(6):511-8). Mice (n=25) were randomized in three arms to treatment with either HOCl (n=10) ;HOCl plus PTU (n=10); or vehicle alone (n=5). PTU treatment was initiated 30 minutes after HOCl subcutaneous injection (12 mg/kg) continuing daily for the 6 weeks. Skin and lung fibrosis were evaluated by histological methods. The severity of fibrosis was assessed using ordinal or nominal scales in both tissues and the results compared nonparametrically.

Results: Injections of HOCl induced both cutaneous and lung fibrosis in BALB/c mice, as reported in the model. Concomitant PTU treatment reduced skin thickness by 77% (images not shown) and reduced pulmonary fibrosis below the level of histological detectability, in effect preventing it entirely in this model. Pulmonary concentrations of VEGF were significantly higher in mice exposed to HOCl (p<0.001) and were reduced by concomitant treatment with PTU (p<0.001). Its downstream mediator ERK (extracellular signal-related kinase) followed the same pattern (images not shown).

Conclusion: PTU-induced hypothyroidism (or the PTU itself, via another mechanism of  action not related to hypothyroidism, such as antioxidant effect) reduced significantly the development of fibrosis in the HOCl mouse model of SSc .  No confirmatory thyroidectomy experiments were performed in this model, in contrast to those reported in the previous rat model.  Further studies are therefore needed to investigate both the roles of thyroid function and reactive oxygen species in scleroderma pathogenesis, including analysis of any direct antioxidant effect of PTU, independent of its effect upon thyroid status. 

 

 

 

 

 


Disclosure:

G. Bagnato,
None;

A. Bitto,
None;

N. Irrera,
None;

G. Pizzino,
None;

N. Roberts,
None;

M. Cinquegrani,
None;

D. Sangari,
None;

F. Squadrito,
None;

G. Bagnato,
None;

A. Saitta,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/propylthiouracil-reduces-fibrosis-in-chronic-oxidant-stress-mouse-model-of-scleroderma/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology